Stepan VP Sells $48,320 in Stock (SCL)
Stepan (NYSE:SCL) VP Frank Pacholec sold 1,000 shares of Stepan stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $48.32, for a total transaction of $48,320.00. Following the transaction, the vice president now directly owns 56,493 shares in the company, valued at approximately $2,729,742. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Stepan (NYSE:SCL) traded down 0.35% on Tuesday, hitting $48.07. 116,203 shares of the company’s stock traded hands. Stepan has a 52 week low of $46.91 and a 52 week high of $67.20. The stock’s 50-day moving average is $50.16 and its 200-day moving average is $56.06. The company has a market cap of $1.072 billion and a price-to-earnings ratio of 16.17.
Stepan (NYSE:SCL) last announced its earnings results on Wednesday, July 23rd. The company reported $1.06 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.01 by $0.05. The company had revenue of $504.10 million for the quarter, compared to the consensus estimate of $498.20 million. Analysts expect that Stepan will post $2.99 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Monday, September 15th. Shareholders of record on Friday, August 29th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Wednesday, August 27th.
A number of analysts have recently weighed in on SCL shares. Analysts at KeyCorp initiated coverage on shares of Stepan in a research note on Tuesday, August 19th. They set a “hold” rating on the stock. Analysts at National Bank Financial initiated coverage on shares of Stepan in a research note on Monday, July 14th. They set an “outperform” rating on the stock.
Stepan Company produces specialty and intermediate chemicals, which are sold to other manufacturers and then made into a variety of end products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.